Home Tags Biotech

Tag: Biotech

Dispensed: Young blood startup is back, a scoop about CityMD, and telling remarks from Merck’s CEO

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.

Array BioPharma spikes more than 50% after Pfizer shells out $11 billion for the cancer-drug developer

Pfizer's blockbuster deal for Array BioPharma is the latest in a growing list of M&A deals to take place in the cancer-treatment space this year.
uBiome is a microbiome testing startup in San Francisco.

Dispensed: The inside story of uBiome, a visit to the largest health system in New York, and what it’s like to take a ‘biotech for dummies...

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.
A class called "Biotech for Non-Scientists" teaches people in the healthcare industry about basic science, including through a lab where they extract DNA from fresh strawberries.

We took the two-day, $1,300 ‘biotech for dummies’ class where healthcare executives, HR managers, and investors catch up on science for th...

At a recent class, a room of buttoned-up professionals from some of the world's biggest companies were mashing up strawberries and giggling.
Elizabeth Holmes, the founder and CEO of Theranos, at the 2015 Wall Street Journal Digital Live conference in Laguna Beach, California.

Why everybody gets duped by hot health and science startups

The Silicon Valley tech ethos of 'move fast and break things' is not being counterbalanced by the healthcare principal of 'do no harm,' experts say.

Dispensed: A record-breaking approval, what it’s like to work in healthcare, and a call for nominations

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.
To prepare for its nationwide launch next week, Impossible Foods had to change the recipe for its "bleeding" veggie burgers.

The inside story of how the Silicon Valley burger startup Impossible Foods is going global after its sizzling Burger King debut

To create the Impossible Burger 2.0, the company had to change the recipe. One tweak that could be controversial involves using genetically modified soy.
Warby Parker and SmileDirectClub are inking deals with insurers.

Dispensed: Troubles at uBiome, pharma giant Merck’s plan to upend the $20 billion HIV market, and why insurers are starting to embrace brands li...

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.
A dermatologist recently started his own platform for cheaper skin medications.

The doctor who helped create a skin-care line for Amazon just started a new website to take on drug companies that charge $2,000 for common creams

Prescriptions to treat acne, burns, and growths can cost hundreds or even thousands of dollars. A new website will sell them for $24 to $60.